R

ReViral

13 employees

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2011

Funding rounds raised

Total raised

$55M

from 13 investors over 13 rounds

R

ReViral raised $44M on August 25, 2020

Investors: New Leaf Venture Partners, OrbiMed Advisors, Andera Partners, Perceptive Advisors, Novo Holdings and Brace Pharma Capital

R

ReViral raised $55M on August 1, 2018

Investors: OrbiMed Advisors, Andera Partners, New Leaf Venture Partners and Perceptive Advisors

R

ReViral raised $21M on September 8, 2015

Investors: Brace Pharma Capital, OrbiMed Advisors and Andera Partners

FAQ